New insights into the management of differentiated thyroid carcinoma in children and adolescents (Review)

  • Authors:
    • André B. Zanella
    • Rafael Selbach Scheffel
    • Letícia Weinert
    • José Miguel Dora
    • Ana Luiza Maia
  • View Affiliations

  • Published online on: March 1, 2021     https://doi.org/10.3892/ijo.2021.5193
  • Article Number: 13
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Differentiated thyroid carcinoma (DTC) is the most common malignant neoplasm of the endocrine system. In children and adolescents, DTC usually presents as a more aggressive disease than in the adult population, but patients often have a favourable prognosis, even in cases of advanced disease. Nevertheless, certain patients have persistent or recurrent disease leading to increased morbidity. A significant challenge in the management of DTC is identifying the subgroup of patients with a high risk of unfavourable outcomes. Prognostic factors related to the patient, tumour, and stratification systems (Tumor‑Node‑Metastasis/American Joint Committee on Cancer, American Thyroid Association risk classification and dynamic risk stratification) are used in an attempt to identify the individuals at increased risk. In the present review, the current risk classification systems applied for paediatric thyroid cancer are discussed, highlighting the major differences between paediatric and adult DTC in pathophysiology, clinical presentation and long‑term outcomes. In recent years, genetic markers have also been proposed as prognostic factors for children and adolescents with DTC. Advances in the understanding of the molecular profile of paediatric DTC may aid individualized management, potentially improving diagnosis and treatment. This review article aims to critically review and update the current concepts on DTC management in children and adolescents, with an emphasis on clinical presentation, treatment, risk assessment, follow‑up and future perspectives.
View Figures
View References

Related Articles

Journal Cover

May-2021
Volume 58 Issue 5

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zanella AB, Scheffel RS, Weinert L, Dora JM and Maia AL: New insights into the management of differentiated thyroid carcinoma in children and adolescents (Review). Int J Oncol 58: 13, 2021.
APA
Zanella, A.B., Scheffel, R.S., Weinert, L., Dora, J.M., & Maia, A.L. (2021). New insights into the management of differentiated thyroid carcinoma in children and adolescents (Review). International Journal of Oncology, 58, 13. https://doi.org/10.3892/ijo.2021.5193
MLA
Zanella, A. B., Scheffel, R. S., Weinert, L., Dora, J. M., Maia, A. L."New insights into the management of differentiated thyroid carcinoma in children and adolescents (Review)". International Journal of Oncology 58.5 (2021): 13.
Chicago
Zanella, A. B., Scheffel, R. S., Weinert, L., Dora, J. M., Maia, A. L."New insights into the management of differentiated thyroid carcinoma in children and adolescents (Review)". International Journal of Oncology 58, no. 5 (2021): 13. https://doi.org/10.3892/ijo.2021.5193